Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
Meghali Goswami, Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez, Dong Yun Kim, Jack Y. Ghannam, Karolyn A. Oetjen, Christin B. Destefano, Dana M. Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Thomas Hughes, Jennifer L. Marté, Jaydira Del Rivero, Joanna Klubo-Gwiezdzinksa, James L. Gulley, Katherine R. CalvoCatherine Lai, Christopher S. Hourigan
Research output: Contribution to journal › Article › peer-review
38Scopus
citations
Fingerprint
Dive into the research topics of 'Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia'. Together they form a unique fingerprint.